arrow
K

Karl Stéfic

university of california-san diego
H指数:22
被引数:3,131

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab

法国全国性真实世界调查:接受含fos-temsavir或ibalizumab的抗逆转录病毒方案的多耐药HIV-1病毒感染者

2026-08-140
OAAI
HIV epidemic and needs beyond fast-track cities: a transmission network analysis to study the dynamics of HIV clusters in a French region near Paris

巴黎附近法国地区HIV流行和需求超出快速通道城市:利用传播网络分析研究HIV聚集的动态性

2026-06-020
PRE
Comparative Evaluation of the New HIV VIDAS® DUO AG/AB Assay With DUO Ultra on Well Characterized Participants From the HIV-1 Acute Infection French ANRS PRIMO Cohort

比较HIV VIDAS® DUO AG/AB新检测法与DUO Ultra在法国ANRS PRIMO队列急性感染期HIV-1感染者中的评估

2026-05-040
OAAI
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study

Omicron感染者重症患者血清中和功能受损及死亡:来自法国SEVARVIR前瞻性、多中心队列研究的启示

2025-11-260
OAAI
Benefits of HIV-1 transmission cluster surveillance: a French retrospective observational study of the molecular and epidemiological co-evolution of recent circulating recombinant forms 94 and 132

HIV-1传播簇监测的益处:一项关于近期流行重组型94和132分子与流行病学协同演化的法国回顾性观察研究

2025-01-281
OAAI
Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study

双重单克隆抗体治疗新型冠状病毒肺炎进化的比较: 多中心回顾性研究

2024-09-290
OAAI
SEVERE ENTEROVIRUS INFECTIONS IN PATIENTS WITH AUTOIMMUNE DISEASES RECEIVING ANTI-CD20 MONOCLONAL ANTIBODIES

自身免疫疾病患者接受抗CD20单克隆抗体治疗后的严重肠道病毒感染

2024-06-010
PRE
Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study

流行病学和临床洞察肠病毒D68热潮在欧洲2021-2022和新的B3-Derived谱系的出现,ENPEN多中心研究

2024-03-288
OAAI
Transmitted Drug Resistance to Integrase-based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe

欧洲地中海地区对基于整合酶的一线人类免疫缺陷病毒抗逆转录病毒疗法的耐药性

2022-12-2627
PRE
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies

接受单克隆抗体的患者血清中和SARS-CoV-2 Omicron BA.2,BA.4和BA.5的纵向分析

2022-12-0145
OAAI